These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15298512

  • 1. Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
    Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Stagg SJ, Chaisson GA, Vitrella DA, Allie SD, Allie AA, Mitran EV, Walker CM.
    J Endovasc Ther; 2004 Aug; 11(4):427-35. PubMed ID: 15298512
    [Abstract] [Full Text] [Related]

  • 2. Tenecteplase in acute lower-leg ischemia: efficacy, dose, and adverse events.
    Hull JE, Hull MK, Urso JA, Park HA.
    J Vasc Interv Radiol; 2006 Apr; 17(4):629-36. PubMed ID: 16614145
    [Abstract] [Full Text] [Related]

  • 3. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
    Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Vivekananthan K, Allie SE, Mitran EV, Chaisson G, Stagg SJ, Allie AA, McElderry MW, Barker EA, Walker CM.
    J Invasive Cardiol; 2005 Aug; 17(8):427-32. PubMed ID: 16079449
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
    Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR.
    J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.
    Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M.
    Stroke; 2003 Aug; 34(8):1932-5. PubMed ID: 12829861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
    Junghans U, Seitz RJ, Wittsack HJ, Aulich A, Siebler M.
    Radiology; 2001 Dec; 221(3):795-801. PubMed ID: 11719681
    [Abstract] [Full Text] [Related]

  • 11. Infusion techniques for peripheral arterial thrombolysis.
    Kessel DO, Berridge DC, Robertson I.
    Cochrane Database Syst Rev; 2004 Dec; (1):CD000985. PubMed ID: 14973961
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
    Kelly RV, Crouch E, Krumnacher H, Cohen MG, Stouffer GA.
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):327-32. PubMed ID: 16208711
    [Abstract] [Full Text] [Related]

  • 14. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.
    Cerebrovasc Dis; 2013 Nov; 35(5):461-8. PubMed ID: 23735898
    [Abstract] [Full Text] [Related]

  • 15. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA, Rosas M, González H, Peña-Duque MA, Martínez-Sánchez C, Gaspar J, García H, Gaxiola E, Delgado L, Carrillo J, Leyva JL, Lupi E, SASTRE Investigators.
    Am J Cardiol; 2004 Feb 01; 93(3):280-7. PubMed ID: 14759375
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab.
    Drescher P, McGuckin J, Rilling WS, Crain MR.
    AJR Am J Roentgenol; 2003 May 01; 180(5):1385-91. PubMed ID: 12704056
    [Abstract] [Full Text] [Related]

  • 18. Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.
    Schweizer J, Kirch W, Koch R, Müller A, Hellner G, Forkmann L.
    Angiology; 2003 May 01; 54(2):155-61. PubMed ID: 12678189
    [Abstract] [Full Text] [Related]

  • 19. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis.
    Kathirvel D, Justin Paul G, Prathap Kumar G, Palanisamy G, Gnanavelu G, Ravishankar G, Swaminathan N, Venkatesan S.
    Indian Heart J; 2018 May 01; 70(4):506-510. PubMed ID: 30170645
    [Abstract] [Full Text] [Related]

  • 20. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications.
    Swischuk JL, Fox PF, Young K, Hussain S, Smouse B, Castañeda F, Brady TM.
    J Vasc Interv Radiol; 2001 Apr 01; 12(4):423-30. PubMed ID: 11287527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.